Wall Street brokerages expect Phibro Animal Health Corp (NASDAQ:PAHC) to post $0.43 earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have issued estimates for Phibro Animal Health’s earnings. Phibro Animal Health posted earnings per share of $0.44 in the same quarter last year, which would indicate a negative year over year growth rate of 2.3%. The business is expected to issue its next earnings results on Monday, February 4th.
According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.72 per share for the current fiscal year, with EPS estimates ranging from $1.69 to $1.74. For the next financial year, analysts forecast that the business will report earnings of $1.77 per share, with EPS estimates ranging from $1.70 to $1.84. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Phibro Animal Health.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $0.39 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.03). The company had revenue of $200.20 million for the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. Phibro Animal Health’s revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS.
NASDAQ PAHC opened at $33.54 on Friday. Phibro Animal Health has a twelve month low of $32.05 and a twelve month high of $54.62. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.82 and a current ratio of 3.26. The company has a market cap of $1.38 billion, a price-to-earnings ratio of 19.28, a PEG ratio of 2.93 and a beta of 0.82.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.43%. The ex-dividend date of this dividend is Tuesday, November 27th. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio is presently 22.99%.
In related news, insider Dean J. Warras sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $42.84, for a total value of $428,400.00. Following the completion of the transaction, the insider now owns 10,000 shares of the company’s stock, valued at $428,400. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jack Bendheim sold 20,000 shares of the firm’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $47.14, for a total transaction of $942,800.00. The disclosure for this sale can be found here. Insiders sold 43,020 shares of company stock valued at $1,978,371 in the last ninety days. Insiders own 50.29% of the company’s stock.
Hedge funds have recently made changes to their positions in the business. Morgan Stanley lifted its stake in shares of Phibro Animal Health by 89.8% during the 3rd quarter. Morgan Stanley now owns 362,872 shares of the company’s stock worth $15,567,000 after buying an additional 171,639 shares during the last quarter. Legal & General Group Plc increased its holdings in Phibro Animal Health by 10.7% in the 3rd quarter. Legal & General Group Plc now owns 43,295 shares of the company’s stock valued at $1,852,000 after buying an additional 4,188 shares during the period. TIAA CREF Investment Management LLC increased its holdings in Phibro Animal Health by 10.1% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 224,815 shares of the company’s stock valued at $9,645,000 after buying an additional 20,562 shares during the period. MetLife Investment Advisors LLC increased its holdings in Phibro Animal Health by 51.1% in the 3rd quarter. MetLife Investment Advisors LLC now owns 15,103 shares of the company’s stock valued at $648,000 after buying an additional 5,110 shares during the period. Finally, Man Group plc increased its holdings in Phibro Animal Health by 8.0% in the 3rd quarter. Man Group plc now owns 162,046 shares of the company’s stock valued at $6,952,000 after buying an additional 12,040 shares during the period. Hedge funds and other institutional investors own 48.33% of the company’s stock.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Further Reading: Stop Order Uses For Individual Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.